Wild-type PCSK9 inhibits LDL clearance but does not affect apoB-containing lipoprotein production in mouse and cultured cells

Wild-type PCSK9 inhibits LDL clearance but does not affect apoB-containing lipoprotein production in mouse and cultured cells

Mutations in Proprotein Convertase Subtilisin Kexin 9 (PCSK9) have been associated with autosomal dominant hypercholesterolemia. In vivo kinetic studies indicate that LDL catabolism was impaired and apolipoprotein B (apoB)-containing lipoprotein synthesis was enhanced in two patients presenting with...

Full description

Bibliographic Details
Main Authors: Florent Lalanne, Gilles Lambert, Marcelo J.A. Amar, Maud Chétiveaux, Yassine Zaïr, Anne-Laure Jarnoux, Khadija Ouguerram, José Friburg, Nabil G. Seidah, H. Bryan Brewer, Jr., Michel Krempf, Philippe Costet
Format: Article
Language:English
Published: Elsevier 2005-06-01
Series:Journal of Lipid Research
Subjects:
Proprotein Convertase Subtilisin Kexin 9
low density lipoprotein
apolipoprotein B
Online Access:http://www.sciencedirect.com/science/article/pii/S0022227520330364

Internet

http://www.sciencedirect.com/science/article/pii/S0022227520330364

Similar Items